首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR IMPROVING RHEOLOGICAL PROPERTIES OF SPUTUM BASED ON ENZYME NUCLEASE SERRATIA MARCESCENS

PHARMACEUTICAL COMPOSITION FOR IMPROVING RHEOLOGICAL PROPERTIES OF SPUTUM BASED ON ENZYME NUCLEASE SERRATIA MARCESCENS

机译:基于酶核酶系列的改善药物的流变特性的药物组合物

摘要

FIELD: medicine.;SUBSTANCE: invention refers to biochemistry and medicine, particularly to high-molecular compounds, as well as to enzymes and aims at improving rheological properties of sputum when treating respiratory diseases. Examples of diseases requiring sputum liquefaction due to difficulty of evacuation include, but are not limited to, cystic fibrosis, chronic bronchitis, tracheobronchitis, laryngitis, Cartagena syndrome, pulmonary emphysema, chronic obstructive pulmonary disease, bronchiectasis, bronchial asthma, sinusitis, and sinusitis.;EFFECT: essence of the technical solution is a pharmaceutical composition for improving the rheological properties of sputum, consisting of a physiological solution and a nuclease enzyme as an active ingredient, which is a product of gene nuc A, or, as a synonym, nuc, found in the genome of bacteria Serratia marcescens or obtained synthetically, providing biosynthesis of catalytically active against high-polymer DNA sputum form of said enzyme when expressed in pro or eukaryotic cells in amount of 0_03–0_1 mg/ml.;4 cl, 6 dwg
机译:技术领域本发明涉及生物化学和医学,特别是高分子化合物以及酶,其目的是在治疗呼吸系统疾病时改善痰的流变性。由于疏散困难而需要痰液化的疾病的例子包括但不限于囊性纤维化,慢性支气管炎,气管支气管炎,喉炎,卡塔赫纳综合症,肺气肿,慢性阻塞性肺病,支气管扩张,支气管哮喘,鼻窦炎和鼻窦炎。 ;效果:该技术方案的实质是一种改善痰液流变特性的药物组合物,它由生理溶液和核酸酶作为有效成分组成,它是基因ucc A或nuc的产物。 ,在粘质沙雷氏菌细菌的基因组中发现或通过合成获得,当在原核或真核细胞中以0_03–0_1 mg / ml的量表达时,可对所述酶的高DNA痰形式的生物活性进行催化合成。; 4 cl,6 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号